Immunosuppression in infants with short bowel syndrome undergoing isolated liver transplantation

Abstract

Children with SBS-IFALD demonstrated adequate absorption of oral tacrolimus without significant acute rejection rate after iLTx suggesting that modification of immunosuppression is not necessary.